{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:34:53Z","timestamp":1789893293455,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jaad.2019.07.060","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T11:37:29Z","timestamp":1564054649000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Pathophysiologic mechanisms of itch in bullous pemphigoid"],"prefix":"10.1016","volume":"83","author":[{"given":"Takashi","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Dorothy","family":"Kursewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Alison","family":"Fayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena Maya","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Nattkemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Yokozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.07.060_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.jaad.2019.07.060_bib2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/exd.13367","article-title":"Complement-independent blistering mechanisms in bullous pemphigoid","volume":"26","author":"Iwata","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.jaad.2019.07.060_bib4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2340\/00015555-2951","article-title":"Eosinophils are a major source of interleukin-31 in bullous pemphigoid","volume":"98","author":"Gehring","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.07.060_bib6","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.actbio.2010.12.007","article-title":"Improving fluorescence imaging of biological cells on biomedical polymers","volume":"7","author":"Jaafar","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jaad.2019.07.060_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2340\/00015555-2417","article-title":"Cutaneous T-cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin","volume":"96","author":"Nattkemper","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.07.060_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jid.2018.09.032","article-title":"Non-histaminergic itch mediators elevated in the skin of a porcine model of scabies and of human scabies patients","volume":"139","author":"Sanders","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2019.07.060_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2017.10.045","article-title":"IL-31: a new key player in dermatology and beyond","volume":"141","author":"Ba\u011fci","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.0022-202x.2001.01505.x","article-title":"Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells","volume":"117","author":"Teraki","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib12","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/eji.201041195","article-title":"TSLP enhances the function of helper type 2 cells","volume":"41","author":"Kitajima","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib13","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1172\/JCI58978","article-title":"Periostin promotes chronic allergic inflammation in response to Th2 cytokines","volume":"122","author":"Masuoka","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaad.2019.07.060_bib14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/exd.13157","article-title":"A possible interaction between periostin and CD163+ skin-resident macrophages in pemphigus vulgaris and bullous pemphigoid","volume":"26","author":"Fujimura","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/exd.13705","article-title":"Possible roles of basophils in chronic itch","author":"Hashimoto","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1398-9995.2011.02570.x","article-title":"Basophil recruitment and activation in inflammatory skin diseases","volume":"66","author":"Ito","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2019.07.060_bib17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/bjd.13875","article-title":"A case of bullous pemphigoid associated with infiltration and activation of basophils","volume":"173","author":"Ugajin","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.alit.2016.10.003","article-title":"The molecular and cellular mechanisms of itch and the involvement of TRP channels in the peripheral sensory nervous system and skin","volume":"66","author":"Kittaka","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaad.2019.07.060_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-662-44605-8_13","article-title":"Protease-activated receptors and itch","volume":"226","author":"Akiyama","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jaad.2019.07.060_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13555-016-0146-1","article-title":"Intraepidermal nerve fiber density: diagnostic and therapeutic relevance in the management of chronic pruritus: a review","volume":"6","author":"Pereira","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2019.07.060_bib21","first-page":"557","article-title":"Research in practice: substance P antagonism in chronic pruritus","volume":"12","author":"Lotts","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2019.07.060_bib22","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","article-title":"Neuropeptide substance P and the immune response","volume":"73","author":"Mashaghi","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaad.2019.07.060_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.165.1.182","article-title":"IL-4 and IFN-up-regulate substance P receptor expression in murine peritoneal macrophages","volume":"165","author":"Marriott","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-5728(98)00025-3","article-title":"Human lymphocytes express substance P and its receptor","volume":"86","author":"Lai","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4049\/jimmunol.141.3.961","article-title":"Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P","volume":"141","author":"Weinstock","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-5728(94)90164-3","article-title":"Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide","volume":"52","author":"Metwali","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/exd.12717","article-title":"Substance P activates human eosinophils","volume":"24","author":"Raap","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib28","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","article-title":"Itch: from mechanism to (novel) therapeutic approaches","volume":"142","author":"Yosipovitch","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaad.2018.02.030","article-title":"Serlopitant for the treatment of chronic pruritus: results of a randomized, multicenter, placebo-controlled phase 2 clinical trial","volume":"78","author":"Yosipovitch","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/00015555-2780","article-title":"Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant","volume":"98","author":"Ohanyan","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.07.060_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-662-44605-8_14","article-title":"NK-1 antagonists and itch","volume":"226","author":"St\u00e4nder","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jaad.2019.07.060_bib32","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/jid.2015.106","article-title":"IL-31 Induces chemotaxis, calcium mobilization, release of reactive oxygen species, and CCL26 in eosinophils, which are capable to release IL-31","volume":"135","author":"Kunsleben","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jdermsci.2017.07.019","article-title":"Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE","volume":"87","author":"Salz","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2019.07.060_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jdermsci.2017.04.008","article-title":"Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid","volume":"87","author":"Bonciani","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2019.07.060_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-1191","article-title":"IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis","volume":"92","author":"Nobbe","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.07.060_bib36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaci.2018.03.018","article-title":"Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study","volume":"142","author":"Kabashima","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2019.07.060_bib38","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.4049\/jimmunol.180.4.2376","article-title":"IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease","volume":"180","author":"Castilow","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.05.008","article-title":"The differential expression of IL-4 and IL-13 and its impact on type-2 immunity","volume":"75","author":"Bao","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaad.2019.07.060_bib40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","article-title":"Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)","volume":"75","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamadermatol.2018.2526","article-title":"Dupilumab for the treatment of recalcitrant bullous pemphigoid","volume":"154","author":"Kaye","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2019.07.060_bib43","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.1721805115","article-title":"BP180 dysfunction triggers spontaneous skin inflammation in mice","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2019.07.060_bib44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2016.05.020","article-title":"Periostin upregulates the effector functions of eosinophils","volume":"138","author":"Noguchi","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2014.02.026","article-title":"Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis","volume":"134","author":"Nakashima","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2018.00407","article-title":"The autoimmune skin disease bullous pemphigoid: the role of mast cells in autoantibody-induced tissue injury","volume":"9","author":"Fang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2019.07.060_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/936545","article-title":"Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis","volume":"2014","author":"Zebrowska","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaad.2019.07.060_bib48","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jid.2018.11.006","article-title":"3-Dimensional optical clearing and imaging of pruritic atopic dermatitis and psoriasis skin reveals downregulation of epidermal innervation","volume":"139","author":"Tan","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.07.060_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fmed.2018.00049","article-title":"Targeting the interleukin-5 pathway for treatment of eosinophilic conditions other than asthma","volume":"5","author":"Roufosse","year":"2018","journal-title":"Front Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219324508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219324508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:56:18Z","timestamp":1759272978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219324508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0190962219324508"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.07.060","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiologic mechanisms of itch in bullous pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.07.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}